Trial intelligence / Profile preview

Drug intervention trial for adult Kashin-Beck disease in Kuasha village

ChiCTR-TRC-08000038Phase 4Recruiting

Sponsor
West China Hospital of Sichuan University
Start
Jan 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of diclofenac and glucosamine sulphate in Kashin-Beck disease (KBD) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Improvement of pain and Multiple indices. Started Jan 2008; status: recruiting.

02

Drugs

diclofenacglucosamine sulphate
03

Conditions

Kashin-Beck disease (KBD)

Beyond the preview

Go deeper on ChiCTR-TRC-08000038.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-08000038.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call